Johnson Investment Counsel’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3,750
Closed -$236K 574
2015
Q3
$236K Buy
3,750
+39
+1% +$2.78K 0.01% 485
2015
Q2
$271K Sell
3,711
-55
-1% -$3.97K 0.01% 462
2015
Q1
$246K Buy
3,766
+31
+0.8% +$2.06K 0.01% 486
2014
Q4
$242K Sell
3,735
-438
-10% -$28.2K 0.01% 492
2014
Q3
$250K Buy
+4,173
New +$273K 0.01% 483

Other funds holding STJ

Johnson Investment Counsel's STJ Position: Q4 2015 in Review

Johnson Investment Counsel sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 3,750 shares — an estimated $236K sold.

Johnson Investment Counsel first reported a position in STJ in Q3 2014 and held it in 5 quarters. The position peaked at $271K in Q2 2015. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Johnson Investment Counsel reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Johnson Investment Counsel sold 3,750 St Jude Medical shares in Q4 2015, an estimated $236K.
  • Johnson Investment Counsel first reported a position in St Jude Medical in Q3 2014 and held it in 5 quarters.
  • Johnson Investment Counsel's St Jude Medical position peaked at $271K in Q2 2015.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Johnson Investment Counsel's 13F filing for Q4 2015, filed 12 Feb 2016.